Article ID Journal Published Year Pages File Type
2108140 Cancer Cell 2011 16 Pages PDF
Abstract

SummaryTumor immune surveillance and cancer immunotherapies are thought to depend on the intratumoral infiltration of activated CD8+ T cells. Intratumoral CD8+ T cells are rare and lack activity. IL-10 is thought to contribute to the underlying immune suppressive microenvironment. Defying those expectations we demonstrate that IL-10 induces several essential mechanisms for effective antitumor immune surveillance: infiltration and activation of intratumoral tumor-specific cytotoxic CD8+ T cells, expression of the Th1 cytokine interferon-γ (IFNγ) and granzymes in CD8+ T cells, and intratumoral antigen presentation molecules. Consequently, tumor immune surveillance is weakened in mice deficient for IL-10 whereas transgenic overexpression of IL-10 protects mice from carcinogenesis. Treatment with pegylated IL-10 restores tumor-specific intratumoral CD8+ T cell function and controls tumor growth.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (144 K)Download as PowerPoint slideHighlights► PEG-IL-10 induces the CD8+ T cell-mediated regression of large tumor masses ► IL-10 directly induces cytotoxic enzymes and IFNγ in CD8+ T cells ► IL-10 induces antigen presentation indirectly through CD8+ T cell-derived IFNγ ► In human tumors, IL-10 expression correlates with granzymes, IFNγ, and MHC

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , , , , , , , , ,